HC Wainwright Weighs in on Edap Tms FY2029 Earnings

Edap Tms S.A. (NASDAQ:EDAP - Free Report) - Stock analysts at HC Wainwright issued their FY2029 EPS estimates for shares of Edap Tms in a report released on Friday, March 28th. HC Wainwright analyst S. Ramakanth anticipates that the medical equipment provider will post earnings of $0.40 per share for the year. HC Wainwright currently has a "Buy" rating and a $19.00 target price on the stock. The consensus estimate for Edap Tms' current full-year earnings is ($0.60) per share.

Edap Tms (NASDAQ:EDAP - Get Free Report) last released its quarterly earnings data on Thursday, March 27th. The medical equipment provider reported ($0.05) earnings per share for the quarter, beating analysts' consensus estimates of ($0.11) by $0.06. Edap Tms had a negative return on equity of 44.21% and a negative net margin of 34.92%. The company had revenue of $22.69 million for the quarter, compared to the consensus estimate of $20.83 million.

A number of other research analysts have also recently issued reports on the company. Piper Sandler cut their price objective on Edap Tms from $5.00 to $4.50 and set an "overweight" rating for the company in a report on Friday. StockNews.com started coverage on shares of Edap Tms in a report on Friday. They set a "hold" rating for the company.

Remove Ads

Edap Tms Stock Performance

EDAP stock remained flat at $1.96 during trading on Monday. The company had a trading volume of 209,847 shares, compared to its average volume of 87,847. The firm's fifty day moving average is $2.42 and its two-hundred day moving average is $2.49. Edap Tms has a twelve month low of $1.90 and a twelve month high of $8.50. The stock has a market capitalization of $72.72 million, a P/E ratio of -3.02 and a beta of 0.37. The company has a current ratio of 2.18, a quick ratio of 1.46 and a debt-to-equity ratio of 0.08.

Hedge Funds Weigh In On Edap Tms

Several institutional investors have recently bought and sold shares of EDAP. Millennium Management LLC increased its stake in shares of Edap Tms by 218.5% in the fourth quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider's stock valued at $108,000 after buying an additional 33,558 shares in the last quarter. BNP Paribas Financial Markets grew its holdings in Edap Tms by 111.5% during the 4th quarter. BNP Paribas Financial Markets now owns 48,650 shares of the medical equipment provider's stock worth $108,000 after acquiring an additional 25,650 shares during the last quarter. Jane Street Group LLC increased its position in Edap Tms by 174.7% in the 4th quarter. Jane Street Group LLC now owns 31,361 shares of the medical equipment provider's stock valued at $69,000 after acquiring an additional 73,361 shares in the last quarter. Schonfeld Strategic Advisors LLC raised its stake in shares of Edap Tms by 48.5% in the fourth quarter. Schonfeld Strategic Advisors LLC now owns 160,800 shares of the medical equipment provider's stock worth $355,000 after acquiring an additional 52,500 shares during the last quarter. Finally, Rock Springs Capital Management LP lifted its position in shares of Edap Tms by 1.5% during the fourth quarter. Rock Springs Capital Management LP now owns 1,591,800 shares of the medical equipment provider's stock worth $3,518,000 after purchasing an additional 23,800 shares in the last quarter. Institutional investors own 62.74% of the company's stock.

Edap Tms Company Profile

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.